Enanta Pharmaceuticals Mean Deviation
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Enanta Pharmaceuticals's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
Enanta Pharmaceuticals registers a Mean Deviation of 0, reflecting low price variability. This places Enanta Pharmaceuticals at the lower end of the volatility range for Stock.
| = | 0 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Enanta Pharmaceuticals |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Enanta Pharmaceuticals and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Mean Deviation |
Maximum Drawdown |
Methodology, Assumptions & Data Sources
The current Mean Deviation for Enanta Pharmaceuticals is 0. Mean Deviation for Enanta Pharmaceuticals is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.